Drug Trial Radar · NCT00056524
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
Last checked: Nov 19, 2026Latest source record: Jul 14, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Planned (sponsor's estimate)
Start
Feb 2003
Primary completion
Jun 2007
Study completion Jun 2007
Sponsor
- Lead sponsor
- Avanir PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 18, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect (episodes of uncontrolled crying and/or laughter).
Conditions
- Alzheimer's Disease
- Stroke
- Parkinson's Disease
- Traumatic Brain Injury
Interventions
AVP-923Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- emotional control
Locations
39 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
Center for Neurologic Study
La Jolla, California
UCLA School of Medicine
Los Angeles, California
UCSF
San Francisco, California
Research Center for Clinical Studies, Inc.
Darien, Connecticut
George Washington University Medical Faculty Assoc.
Washington D.C., District of Columbia
Neurological Associates
Fort Lauderdale, Florida
University of Miami Dept. of Neurology
Miami, Florida
Miami Jewish Home & Hospital for the Aged
Miami, Florida
Allied Clinical Trials
Miami, Florida
Renstar Medical Research
Plantation, Florida
Suncoast Neuroscience Associates Inc.
St. Petersburg, Florida
Site not named
Tampa, Florida
Neurology & Headache Specialist of Atlanta, L.L.C.
Decatur, Georgia
Consultants in Neurology LTD
Northbrook, Illinois
Advanced Neurology Specialists
Great Falls, Montana
Neurological Associates, P.C.
Lincoln, Nebraska
Upstate Clinical Research
Albany, New York
DENT Neurologic Group L.L.P.
Amherst, New York
Hospital for Joint Diseases MS Care Center
New York, New York
SUNY Upstate Medical University
Syracuse, New York
Carolinas Medical Center
Charlotte, North Carolina
Raleigh Neurology Associates, PA
Raleigh, North Carolina
NeuroCare Center, Inc.
Canton, Ohio
MetroHealth Medical Center
Cleveland, Ohio
University Memory and Aging Center
Cleveland, Ohio
The Cleveland Clinic Foundation
Cleveland, Ohio
Clinical Pharmaceutical Trials, Inc.
Tulsa, Oklahoma
Lehigh Valley Neurosciences and Pain Research Center
Allentown, Pennsylvania
Westmoreland Neurology
Greensburg, Pennsylvania
Site not named
Jenkintown, Pennsylvania
MCP-Hahnemann University
Philadelphia, Pennsylvania
Penn Neurological Institute
Philadelphia, Pennsylvania
Neurological Associates of Delaware Valley
Upland, Pennsylvania
Claghorn-Lesem Research Clinic
Bellaire, Texas
Methodist Neurological Institute
Houston, Texas
Fletcher Allen Health Care
Burlington, Vermont
Neurology and Neurosurgery Associates of Tacoma
Tacoma, Washington
University of Wisconsin
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.